Andover Eye Associates

Andover, Massachusetts 01840

2 studies enrolling now · 83 studies all time

What they study most

Age Factor, Age Related Macular Degeneration, Age-Related Macular Degeneration, Age-related Macular Degeneration, Allergic Conjunctivitis, Allergic Rhinitis, Atopic Keratoconjunctivitis, Blepharitis, Cataract, Chronic Allergic Conjunctivitis, Contact Lens Complication, Corneal Disease

Studies at this site

• Randomized Single Center Study to Evaluate Tolerability, Symptoms, and Visual Functional Outcomes With the Use of OTC Lubricating Eye Drops in Subjects With Dry Eye Disease — Recruiting now
• Study of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy — Recruiting now
• A Study to Explore Signs, Symptoms, and Biomarkers in Dry Eye Disease Participants Following Anti-inflammatory Treatment — Completed
• Phase 2 Study of BL1107 Eye Drops vs. Timolol in Adults With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• A Study to Demonstrate How Well REGN1908-1909 Works in Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Cat Allergy — Completed
• Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment — Completed
• Safety and Efficacy of BRM421 for Dry Eye Syndrome — Completed
• A Study to Demonstrate the Effect of REGN5713-5715 on Reducing Ocular Allergy Signs and Symptoms in Adult Participants With Birch Pollen Allergy — Completed
• A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes — Completed
• An Investigation of FID 123320 for the Reduction of Ocular Redness in Pediatric and Adult Populations — Completed
• A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease — Completed
• A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled, Parallel-Group Clinical Trial Evaluating the Safety of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease — Completed
• Study Evaluating the Safety and Efficacy of AR-15512 (COMET-3) — Completed
• A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Clinical Trial of Reproxalap to Assess the Safety and Efficacy in Subjects With Dry Eye Disease — Completed
• A Clinical Trial to Assess Subjects With Dry Eye Disease. — Completed
• ALLEVIATE Trial - A Phase 3 Trial in Subjects With Allergic Conjunctivitis — Completed
• A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease — Completed
• A Randomized, Double Masked, Clinical Study of Subjects With Dry Eye Syndrome — Completed
• Prospective, Randomized, Controlled Agreement and Reproducibility Clinical Study — Completed
• A Phase 3, Multi-Center Study Evaluating PL9643 in Patients with Dry Eye — Completed
• A Phase 2b Study Evaluating the Safety and Efficacy of AR-15512 Ophthalmic Solution for the Treatment of Dry Eye Disease — Completed
• Phase 2, Multi-center, Randomized, Double- Masked and Placebo-Controlled Study of YP-P10 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (ICECAP 1) — Completed
• A Study Of TL-925 For The Treatment of AC — Completed
• A Clinical Study Comparing the Comfort of Three Commercially Available Contact Lenses — Withdrawn before enrolling
• Visual Function Tests in Age-related Macular Degeneration — Stopped early
• Study of ST-100 as Treatment for Dry Eye Disease — Completed
• A Study to Assess Efficacy of HL036 in Subjects With Dry Eyes — Completed
• Safety and Efficacy of TOP1630 for Dry Eye Syndrome — Completed
• The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease — Completed
• Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) — Status unconfirmed
• Safety and Efficacy of TP-03 for the Treatment of Demodex Blepharitis — Completed
• A Study of TL-925 for the Treatment of Allergic Conjunctivitis — Status unconfirmed
• A Study of TL-925 as a Treatment for Dry Eye Disease — Completed
• A Study to Evaluate AXR-159 Ophthalmic Solution in Patients With Dry Eye Disease — Completed
• Agreement and Precision Study of the Nidek Mirante — Completed
• Comparative Study of the NIDEK TONOREF III and the Haag-Streit Goldmann Manual Tonometer and Comparison of Pachymetry Values for NIDEK TONOREF III With the NIDEK CEM-530 — Completed
• Mucin Levels in Dry Eye and Normal Populations — Completed
• A Study to Evaluate the Efficacy of Investigational OTC Eye Drops — Completed
• A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model. — Completed
• A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease — Completed
• Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis — Completed
• A Single-Center, Double-Masked Evaluation of the Efficacy and Safety of PRX-100 in the Treatment of Early to Moderate Presbyopia — Completed
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Flonase® Allergy Relief in Subjects With Allergic Conjunctivitis — Completed
• Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements — Completed
• Comparative Study of Non-contact Tonometers for Intraocular Pressure and Corneal Cell Thickness Measurements — Completed
• Second Comparative Study of Specular Microscopes for Endothelial and Corneal Cell Measurements — Completed
• Comparative Study of the Topcon Tonometers CT-800 and TRK-2P and the Haag-Streit Goldmann Manual Tonometer and Topcon SP-1P — Completed
• An Evaluation of the Clinical Utility and Safety of the Visant Medical Canalicular Plug — Completed
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3 — Completed
• A Study Comparing the Efficacy of Pataday® Once Daily Relief Extra Strength to Claritin® Tablets 24-Hour in Subjects With Allergic Conjunctivitis — Completed